Gini F. Fleming

Also affiliated with University of Chicago Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.2Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-06943-x

Top 27%

0.737DataRank

Top 27%18 citations

Jori Sheade, Fangyuan Zhao, Frederick M. Howard, Nora Jaskowiak, Jennifer F. Tseng +6 more

Papers

Driven by 22 papers — median percentile 66. Top paper: “Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT”.

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Journal of Clinical Oncology(2022)10.1200/jco.22.01065

N/A

2.2DataRank · unranked

59 citations

Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet +22 more

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer

Journal of Clinical Investigation(2022)10.1172/jci158800

N/A

1.8DataRank · unranked

73 citations

Ping Xie, Matthew Cowan, Hao Huang, Horacio Cárdenas, Russell Keathley +10 more

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases

Journal of Clinical Investigation(2023)10.1172/jci162260

N/A

1.1DataRank · unranked

22 citations

Benjamin E. Onderdonk, Rebekah Dadey, Jared H. Hara, Lilit Karapetyan, Yuanyuan Zha +8 more

The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-06943-x

Top 27%

0.737DataRank

Top 27%18 citations

Jori Sheade, Fangyuan Zhao, Frederick M. Howard, Nora Jaskowiak, Jennifer F. Tseng +6 more

Racial disparities in survival outcomes among breast cancer patients by molecular subtypes

Breast Cancer Research and Treatment(2021)10.1007/s10549-020-05984-w

N/A

0.581DataRank · unranked

47 citations

Brenda Copley, Qun Niu, Fang Liu, Julie A. Johnson, Thomas Sutton +11 more

Validation of the RSClin risk calculator in the National Cancer Data Base

Cancer(2023)10.1002/cncr.35163

Top 40%

0.479DataRank

Top 40%8 citations

Asim Dhungana, Fangyuan Zhao, Nan Chen, Sarah P. Shubeck, Olwen Hahn +8 more

Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study

Applied immunohistochemistry & molecular morphology(2021)10.1097/pai.0000000000000949

N/A

0.399DataRank · unranked

5 citations

Virginia L. Filiaci, Anthony G. Montag, Marsha Apushkin, Maria J. Gomez, Laura Monovich +9 more

The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast Cancer

HAL (Le Centre pour la Communication Scientifique Directe)(2023)10.21203/rs.3.rs-2667554/v1

N/A

0.396DataRank · unranked

13 citations

Jori Sheade, Fangyuan Zhao, Frederick M. Howard, Nora Jaskowiak, Jennifer F. Tseng +6 more

High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100987

N/A

0.241DataRank · unranked

4 citations

M. Steiner, Ricardo R. Lastra, S. John Weroha, John Cursio, Ernst Lengyel +3 more

Phase II study of pembrolizumab plus mifepristone in patients with advanced HER2-negative breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1095

N/A

0.104DataRank · unranked

1 citations

Elena Michaels, Poornima Saha, Murtuza Rampurwala, Olwen Hahn, Frederick M. Howard +5 more

A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.02.031

N/A

0DataRank · unranked

52 citations

Larissa V. Furtado, Ana I. Tergas, Nita K. Lee, Rebecca Brooks, Anne R. McCall +17 more

Treatment outcomes in patients with discordant recurrence score and RSClin risk predictions.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.574

N/A

0DataRank · unranked

0 citations

Asim Dhungana, Fangyuan Zhao, Nan Chen, Sarah P. Shubeck, Olwen Hahn +8 more

Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models

Journal of Gynecologic Oncology(2024)10.3802/jgo.2025.36.e4

N/A

0DataRank · unranked

2 citations

Xiaonan Hou, Jennifer Veneris, N Kazi, Melissa C. Larson, Matthew J. Maurer +8 more

Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.026

N/A

0DataRank · unranked

6 citations

Chunqiao Tian, Jordyn Tumas, Neil T. Phippen, Christopher M. Tarney, Erica Hope +22 more

Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer

Journal of Oncology Pharmacy Practice(2024)10.1177/10781552241289581

N/A

0DataRank · unranked

0 citations

Elena Michaels, Eric C. Polley, Peter H. O’Donnell, Frederick M. Howard, Olwen Hahn +5 more

Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.001

N/A

0DataRank · unranked

8 citations

Ernst Lengyel, Andrea E. Wahner Hendrickson, Gustavo C. Rodriguez, Charles A. Leath, Rodney P. Rocconi +6 more

Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.08.025

N/A

0DataRank · unranked

4 citations

Gabrielle Sudilovsky, Yan Che, Austin Wesevich, Sandra Tilmon, Nita K. Lee +3 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07626-5

N/A

0DataRank · unranked

2 citations

Margarite D. Matossian, Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn +8 more

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931

N/A

0DataRank · unranked

2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

Annals of Oncology(2023)10.1016/j.annonc.2023.01.009

N/A

0DataRank · unranked

48 citations

Giuseppe Viale, Serena Nik‐Zainal, Peter Savas, Roswitha Kammler, Patrizia Dell’Orto +33 more

A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6010

N/A

0DataRank · unranked

29 citations

Daniela Matei, Panagiotis A. Konstantinopoulos, Matthew S. Block, Andrea Jewell, Stéphanie Gaillard +15 more

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13103

N/A

0DataRank · unranked

3 citations

Poornima Saha, Murtuza Rampurwala, Sailaja Kamaraju, Olwen Hahn, Frederick M. Howard +8 more

Gini F. Fleming

Indexed papers

Top data-sharing exemplar

Papers